BioLineRx Ltd. Adjusted Weighted Average Shares
BioLineRx Ltd. (BLRX) reported Adjusted Weighted Average Shares of 2.47 billion shares for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-23.
Financial Statements › Income Statement › Earnings Per Share
ifrs-full:AdjustedWeightedAverageShares · last filed 2026-03-23
- BioLineRx Ltd. adjusted weighted average shares for the quarter ending 2024-06-30 was 1.20B shares, a 29.75% increase year-over-year.
- BioLineRx Ltd. adjusted weighted average shares for the quarter ending 2023-06-30 was 922.96M shares.
| Period end | Adjusted Weighted Average Shares 3 month | Adjusted Weighted Average Shares 6 month | Adjusted Weighted Average Shares 12 month |
|---|---|---|---|
| 2025-12-31 | 2.47B shares 20-F · filed 2026-03-23 | ||
| 2024-12-31 | 1.20B shares 20-F · filed 2026-03-23 | ||
| 2024-06-30 | 1.20B shares 6-K · filed 2024-08-15 | 1.14B shares 6-K · filed 2024-08-15 | |
| 2023-12-31 | 963.37M shares 20-F · filed 2026-03-23 | ||
| 2023-06-30 | 922.96M shares 6-K · filed 2024-08-15 | 922.96M shares 6-K · filed 2024-08-15 |